Ann Walawander

755 total citations
6 papers, 220 citations indexed

About

Ann Walawander is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Ann Walawander has authored 6 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Emergency Medicine. Recurrent topics in Ann Walawander's work include HIV/AIDS drug development and treatment (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Ann Walawander is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Ann Walawander collaborates with scholars based in United States, Zimbabwe and India. Ann Walawander's co-authors include Carl J. Fichtenbaum, Michael N. Dohn, John R. Black, Simone Becker, Dianne M. Finkelstein, Michael F. Para, Susan L. Koletar, F Holland, Joseph J. Eron and Michael S. Saag and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Ann Walawander

6 papers receiving 212 citations

Peers

Countries citing papers authored by Ann Walawander

Since Specialization

Citations

This map shows the geographic impact of Ann Walawander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Walawander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Walawander more than expected).

Fields of papers citing papers by Ann Walawander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Walawander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Walawander. The network helps show where Ann Walawander may publish in the future.

Co-authorship network of co-authors of Ann Walawander

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Walawander. A scholar is included among the top collaborators of Ann Walawander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Walawander. Ann Walawander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial 2014 ·PLoS ONE ·Steven A. Safren, Katie B. Biello, Laura Smeaton, Matthew J. Mimiaga, Ann Walawander, Javier R. Lama, Aadia Rana, Mulinda Nyirenda, (unknown), Wadzanai Samaneka, (unknown), David D. Celentano, Ana Martı́nez, Jocelyn E. Remmert, (unknown), Umesh Lalloo, Nagalingeswaran Kumarasamy, James Hakim, Thomas Campbell, (unknown)	46
2	Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease 2013 ·PLoS ONE ·André Reynaldo Santos Périssé, Laura Smeaton, Yun Chen, Alberto La Rosa, Ann Walawander, (unknown), Beatriz Grinsztejn, Breno Santos, Cecilia Kanyama, James Hakim, Mulinda Nyirenda, Nagalingeswaran Kumarasamy, Umesh Lalloo, Timothy Flanigan, Thomas Campbell, Michael D. Hughes, (unknown)	4
3	Comparison of Two Indinavir/Ritonavir Regimens in the Treatment of HIV-Infected Individuals 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Edward P. Acosta, Hulin Wu, Scott M. Hammer, Yu Song, Daniel R. Kuritzkes, Ann Walawander, Joseph J. Eron, Carl J. Fichtenbaum, Carla Pettinelli, (unknown), Elaine Ferguson, Alfred J. Saah, John G. Gerber	59
4	Refractory Mucosal Candidiasis in Advanced Human Immunodeficiency Virus Infection 2000 ·Clinical Infectious Diseases ·Carl J. Fichtenbaum, Susan L. Koletar, Constantin T. Yiannoutsos, F Holland, John C. Pottage, Susan E. Cohn, Ann Walawander, Peter T. Frame, Judith Feinberg, Michael S. Saag, Charles van der Horst, William G. Powderly	65
5	Reduced Toxicity With Gradual Initiation of Trimethoprim-Sulfamethoxazole as Primary Prophylaxis for Pneumocystis carinii Pneumonia: AIDS Clinical Trials Group 268 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Michael F. Para, Dianne M. Finkelstein, Simone Becker, Michael N. Dohn, Ann Walawander, John R. Black	33
6	Reduced Toxicity With Gradual Initiation of Trimethoprim-Sulfamethoxazole as Primary Prophylaxis for Pneumocystis carinii Pneumonia: AIDS Clinical Trials Group 268 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Michael F. Para, Dianne M. Finkelstein, Simone Becker, Michael N. Dohn, Ann Walawander, John R. Black	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact